CVS Health is launching a new company, Cordavis, to commercialize and produce biosimilar drugs, the cheaper versions of expensive prescriptions derived from biotechnology.
CVS Health Launches Company To Produce Cheaper ‘Biosimilar’ Versions Of Expensive Biotech Drugs
